
Aligning Therapeutic & Diagnostic Programs

TRANSLATION
Aligning therapeutic, biomarker and companion diagnostic development
​
-
Biomarker feasibility and performance
-
Diagnostic partner selection
-
Operational scorecard
-
Track record
-
Platform
-
Global reach
-
Commercialization capability
-
Pricing & cost
-

IMPLEMENTATION
Comprehensive operational support
​
-
Development and deployment of RFIs and RFPs
-
Contracts
-
Structure
-
Negotiation
-
Execution
-
-
Regulatory roadmaps and strategy
-
Technical advisory
-
Operational logistics
-
Program management and oversight

COMMERCIALIZATION
Marketing & messaging
​
-
CDX Life Cycle Management
-
Awareness and education
-
Medical affairs content and strategy
-
Patient insights and voice
-
Patient-focused marketing 360
-
Inspire
-
Facebook
-
Instagram
-
Advocacy channels
-
-
-
Reimbursement

Enabling Precision Medicine

INSIGHTS
Customized surveys
​
-
Integrated with market and technology trends
-
Research with key stakeholders
-
Peers
-
Customers
-
End Users
-
Key opinion leaders
-
Subject matter experts
-

ASSESSMENTS
Areas of focus
​
-
Competitive landscape analysis
-
Therapeutic asset review
-
Technology and platform evaluations
-
In vitro diagnostic strategy
-
Investor diligence

EDUCATION
Seminars for Pharma​
​
-
Companion diagnostic bootcamp
-
IVD regulatory trends and strategy
-
Drug/Diagnostic co-commercialization options
Meet The Partners

Joe Monforte PhD
-
25 years Life Sciences Entrepreneur
​
-
Company building – 18 years in the CSO role
​
-
Diagnostic product strategy and tactical development
​
-
Drug Diagnostic companion (CDx) codevelopment program support
​
-
Rx/Dx patient messaging and engagement
​
-
Genomics and NGS technology expert

Pia Gargiulo PhD
-
20 years Pharma/Dx Product and BD Executive
​
-
Translational & Transactional driver
​
-
Out of the box strategist
​
-
Patient advocate and engagement expert
​
-
Specialized experience in companion diagnostic (CDx) Co-Commercialization
​
-
6 PMA (Her2, EGFR, KRAS) 8 CDx Programs Executed